TSX-V:IBT - TSX Venture Exchange - CA4489375085 - Common Stock - Currency: CAD
TSX-V:IBT (4/5/2024, 7:00:00 PM)
1.44
0 (0%)
The current stock price of IBT.CA is 1.44 CAD. In the past month the price increased by 2.86%. In the past year, price increased by 89.47%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 310.73M | ||
EDT.CA | SPECTRAL MEDICAL INC | N/A | 236.65M | ||
EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 192.87M | ||
TH.CA | THERATECHNOLOGIES INC | N/A | 161.39M | ||
MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 75.09M | ||
COV.CA | COVALON TECHNOLOGIES LTD | 14.18 | 66.08M | ||
MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 60.21M | ||
BLU.CA | BLUENERGIES LTD | N/A | 59.60M | ||
HBP.CA | HELIX BIOPHARMA CORP | N/A | 48.78M | ||
MBX.CA | MICROBIX BIOSYSTEMS INC | 33 | 46.46M | ||
SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 44.58M | ||
ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 40.86M |
IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The company is headquartered in Montreal, Quebec. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The firm also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The firm has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The firm operates in one industry segment: the production and sale of diagnostic products.
IBEX TECHNOLOGIES INC
Suite 100, 5485 Pare Street
MONTREAL QUEBEC H4P 1P7 CA
CEO: Paul Baehr
Employees: 0
Phone: 15143444004
The current stock price of IBT.CA is 1.44 CAD.
The exchange symbol of IBEX TECHNOLOGIES INC is IBT and it is listed on the TSX Venture Exchange exchange.
IBT.CA stock is listed on the TSX Venture Exchange exchange.
IBEX TECHNOLOGIES INC (IBT.CA) has a market capitalization of 35.30M CAD. This makes IBT.CA a Nano Cap stock.
IBEX TECHNOLOGIES INC (IBT.CA) currently has 0 employees.
IBEX TECHNOLOGIES INC (IBT.CA) has a support level at 1.43 and a resistance level at 1.45. Check the full technical report for a detailed analysis of IBT.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
IBT.CA does not pay a dividend.
IBEX TECHNOLOGIES INC (IBT.CA) will report earnings on 2021-12-15.
The PE ratio for IBEX TECHNOLOGIES INC (IBT.CA) is 9. This is based on the reported non-GAAP earnings per share of 0.16 and the current share price of 1.44 CAD. Check the full fundamental report for a full analysis of the valuation metrics for IBT.CA.
ChartMill assigns a technical rating of 10 / 10 to IBT.CA. When comparing the yearly performance of all stocks, IBT.CA is one of the better performing stocks in the market, outperforming 94.53% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to IBT.CA. Both the health and profitability get an excellent rating, making IBT.CA a very profitable company, without any liquidiy or solvency issues.
Over the last trailing twelve months IBT.CA reported a non-GAAP Earnings per Share(EPS) of 0.16. The EPS increased by 139.95% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 51.82% | ||
ROA | 22.64% | ||
ROE | 28.25% | ||
Debt/Equity | 0.1 |